Evidence map›Paper›PMID 40826914›Full record

ArticleDiabetes, obesity & metabolism2025

Understanding the clinical characteristics associated with health care costs and cost savings upon weight reduction in individuals with obesity or overweight.

Xuan Li, Carlos Vallarino, Max Denning, Theresa H Gibble, David Schapiro, Dongju Liu, Alice Li, Jennifer M Ward, Jonathan Pearson-Stuttard

Abstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xuan LiEli Lilly and Company, Indianapolis, Indiana, USA.ORCID 0000-0002-6169-2640
Carlos VallarinoEli Lilly and Company, Indianapolis, Indiana, USA.
Max DenningEli Lilly and Company, Indianapolis, Indiana, USA.
Theresa H GibbleEli Lilly and Company, Indianapolis, Indiana, USA.
David SchapiroEli Lilly and Company, Indianapolis, Indiana, USA.
Dongju LiuEli Lilly and Company, Indianapolis, Indiana, USA.
Alice LiEli Lilly and Company, Indianapolis, Indiana, USA.
Jennifer M WardEli Lilly and Company, Indianapolis, Indiana, USA.
Jonathan Pearson-StuttardLane Clark & Peacock LLP, London, UK.ORCID 0000-0003-2175-9975

Funding

Eli Lilly and Company
6 · The paper itself

Abstract

aimsThis study aimed to (1) identify characteristics of people with obesity or overweight that are predictive of health care costs; and (2) identify potential subgroups associated with weight reduction and cost savings following weight reduction interventions. MATERIALS AND

methodsThis retrospective cohort study used the Optum MarketClarity database from 2014 to 2022. The primary objective was assessed among individuals ≥19 years old with obesity/overweight with ≥12 months of continuous medical/pharmacy enrolment (primary cohort; index date: date of body mass index [BMI] measure ≥27 kg/m

resultsOutpatient visits, inpatient days, emergency room visits, and Charlson Comorbidity Index were main drivers of health care costs in GLM and RF models. Obesity-related complications (ORCs) including gastroesophageal reflux disease, osteoarthritis-knee and hip, coronary heart disease, hypertension, and heart failure were also influential predictors of cost, associated with approximately 2-4-fold higher median costs. The strongest predictors of cost savings and ≥10% weight reduction were baseline costs, outpatient visits (OMM cohort) and metabolic syndrome (surgery cohort).

conclusionsFindings underscore ORCs as key drivers of health care costs and highlight the need for targeted treatment strategies to effectively manage obesity, reduce the risk and severity of ORCs, and control health care costs. Furthermore, understanding baseline costs and treatment-related cost trajectories across patient subgroups offers critical insights to inform both clinical decision-making and health policy design.

Indexed as

Cost SavingsHealth Care CostsObesityOverweightWeight LossAdultAgedBariatric SurgeryBody Mass IndexFemaleHumansMaleMiddle AgedRetrospective StudiesWeight Reduction Programshealth care costsobesityobesity‐related complicationsweight reduction intervention

Identifiers

PMID40826914
PMCPMC12515767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.